We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+13.96%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$227M
AUM Growth
+$22.6M
Cap. Flow
-$287K
Cap. Flow %
-0.13%
Top 10 Hldgs %
66.37%
Holding
679
New
65
Increased
149
Reduced
114
Closed
72

Sector Composition

Rank Sector Weight
1 Healthcare 18.25%
2 Financials 4.64%
3 Technology 3.9%
4 Industrials 1.41%
5 Consumer Discretionary 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJJ icon
26
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.82B
$1.2M 0.53%
9,287
-199
-2% -$25.5K
IVE icon
27
iShares S&P 500 Value ETF
IVE
$48.8B
$1.19M 0.52%
5,763
-116
-2% -$23.3K
TWST icon
28
Twist Bioscience
TWST
$5.84B
$1.11M 0.49%
39,462
+947
+2% +$28.7K
IWN icon
29
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.07M 0.47%
6,027
-153
-2% -$25.8K
XENE icon
30
Xenon Pharmaceuticals
XENE
$6.6B
$1.05M 0.46%
26,100
XEL icon
31
Xcel Energy
XEL
$49.2B
$1.04M 0.46%
12,937
+72
+0.6% +$5.21K
LQD icon
32
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$987K 0.43%
8,857
-157
-2% -$17.3K
AGG icon
33
iShares Core US Aggregate Bond ETF
AGG
$139B
$896K 0.39%
8,937
-142
-2% -$14.1K
HCAT icon
34
Health Catalyst
HCAT
$166M
$884K 0.39%
310,282
+145,532
+88% +$498K
EWTX icon
35
Edgewise Therapeutics
EWTX
$4.28B
$863K 0.38%
53,179
+1,114
+2% +$15.8K
CRNX icon
36
Crinetics Pharmaceuticals
CRNX
$8.88B
$833K 0.37%
19,995
INSM icon
37
Insmed
INSM
$23.5B
$828K 0.36%
5,750
-260
-4% -$31.9K
USB icon
38
US Bancorp
USB
$98.4B
$813K 0.36%
16,817
+76
+0.5% +$3.59K
VTI icon
39
Vanguard Total Stock Market ETF
VTI
$658B
$805K 0.35%
2,454
-4
-0.2% -$1.26K
PG icon
40
Procter & Gamble
PG
$349B
$793K 0.35%
5,163
+20
+0.4% +$3.12K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$785K 0.35%
1,178
-11
-0.9% -$7.05K
SPEM icon
42
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$735K 0.32%
15,700
-2,920
-16% -$130K
NPCE icon
43
Neuropace
NPCE
$548M
$650K 0.29%
63,000
HSBC icon
44
HSBC
HSBC
$345B
$639K 0.28%
9,008
ABT icon
45
Abbott
ABT
$175B
$577K 0.25%
4,310
+11
+0.3% +$1.44K
ECL icon
46
Ecolab
ECL
$76.8B
$572K 0.25%
2,088
+5
+0.2% +$1.36K
AMZN icon
47
Amazon
AMZN
$2.66T
$557K 0.25%
2,554
-1,017
-28% -$230K
OEF icon
48
iShares S&P 100 ETF
OEF
$20.1B
$512K 0.23%
1,538
MO icon
49
Altria Group
MO
$124B
$501K 0.22%
7,588
+62
+0.8% +$3.93K
KRMD icon
50
KORU Medical Systems
KRMD
$189M
$463K 0.2%
120,935

Similar funds

HighMark Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, HighMark Wealth Management held 679 positions worth $227M, up 11% from $205M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q3 2025 filing shows 65 new, 149 increased, 114 reduced and 72 closed positions. Its largest new stake was VanEck Semiconductor ETF: 159 shares worth $52K. The largest sale was iShares MSCI EAFE Value ETF, an estimated $679K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q3 2025 buy was VanEck Semiconductor ETF: 159 shares worth $52K.
  • HighMark Wealth Management added most to NeoGenomics in Q3 2025, an estimated $1.93M increase.
  • HighMark Wealth Management's biggest Q3 2025 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $679K.
  • HighMark Wealth Management fully exited Workday in Q3 2025, selling an estimated $110K.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $227M portfolio in Q3 2025.
  • HighMark Wealth Management opened 65 new positions and closed 72 in Q3 2025.
  • HighMark Wealth Management's portfolio value rose 11% quarter-over-quarter to $227M.

Based on HighMark Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.